Supplementary Figure S2 from Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients With HER2-Expressing Solid Tumors: A Phase 1 Dose Escalation Study
Authors:
- Funda Meric-BernstamFMFunda Meric-Bernstam
- Emiliano CalvoECEmiliano Calvo
- Keun Seok LeeKLKeun Seok Lee
- Victor MorenoVictor Moreno
- Yeon Hee ParkYeon Hee Park
- Sun Young RhaSRSun Young Rha
- Pavani ChalasaniPCPavani Chalasani
- Wei ZhongWZWei Zhong
- Li ZhouLZLi Zhou
- Steven Pirie-ShepherdSPSteven Pirie-Shepherd
- Abraham Cf. LeungALAbraham Cf. Leung
- Giuseppe CuriglianoGCGiuseppe Curigliano
Open Access
- 16 September 2024
- other
- Published by American Association for Cancer Research (AACR)